‪Patricia R. Freeman, PhD, RPh, FAPhA, FNAP‬

Geciteerd door

	Alles	Sinds 2019
Citaties	2592	1503
h-index	28	20
i10-index	45	34

340

170

255

20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202412 19 29 34 27 22 29 43 65 53 64 70 87 86 82 79 115 110 177 262 283 317 324 130

Openbare toegang

Alles bekijken

42 artikelen

1 artikel

beschikbaar

niet beschikbaar

Op basis van financieringsmachtigingen

Medeauteurs

Jeffery TalbertProfessor and Division Chief, Biomedical Informatics, University of KentuckyGeverifieerd e-mailadres voor uky.edu
Svetla SlavovaProfessor, University of KYGeverifieerd e-mailadres voor email.uky.edu
Michelle LofwallUniversity of KentuckyGeverifieerd e-mailadres voor uky.edu
Amie GoodinAssistant Professor, University of Florida. Pharmaceutical Outcomes & Policy.Geverifieerd e-mailadres voor ufl.edu
Chris Delcher, PhDUniversity of Kentucky, Institute for Pharmaceutical Outcomes & PolicyGeverifieerd e-mailadres voor uky.edu
Daniela C MogaUniversity of KentuckyGeverifieerd e-mailadres voor uky.edu
Amanda Fallin-BennettAssistant ProfessorGeverifieerd e-mailadres voor uky.edu
Emily HankoskyUniversity of KentuckyGeverifieerd e-mailadres voor uky.edu
Minji SohnAssociate Professor of Pharmacy, Ferris State UniversityGeverifieerd e-mailadres voor ferris.edu
GYeon OhPostdoctoral Scholar, University of KentuckyGeverifieerd e-mailadres voor uky.edu
Heather M BushUniversity of KentuckyGeverifieerd e-mailadres voor uky.edu
Bradley C MartinUniversity of Arkansas for Medical SciencesGeverifieerd e-mailadres voor uams.edu
Nathan PaulyDirector of Medicaid Research and Evaluation, West Virginia University School of Public HealthGeverifieerd e-mailadres voor hsc.wvu.edu
Erin AbnerAssociate Professor of Epidemiology, University of KentuckyGeverifieerd e-mailadres voor uky.edu
David W. FardoProfessor of Biostatistics, University of KentuckyGeverifieerd e-mailadres voor uky.edu
GQ ZhangProfessor and Distinguished Chair in Digital Innovation at University of Texas Health Science CenterGeverifieerd e-mailadres voor uth.tmc.edu
Linda DwoskinProfessor, University of KentuckyGeverifieerd e-mailadres voor uky.edu
Holly DivineUniversity of Kentucky College of PharmacyGeverifieerd e-mailadres voor uky.edu
Sajjad FouladvandJohnson & Johnson Innovative MedicineGeverifieerd e-mailadres voor its.jnj.com
Jin ChenDepartment of Medicine, Department of Biomedical Informatics, University of Alabama at BirminghamGeverifieerd e-mailadres voor uab.edu

Volgen

Patricia R. Freeman, PhD, RPh, FAPhA, FNAP

Earl Platt Slone Endowed Professor, Pharmacy Practice and Science, University of Kentucky

Geverifieerd e-mailadres voor uky.edu

substance use policy pharmaceutical policy health outcomes health policy pharmacy practice


Titel Sorteren op citaties Sorteren op jaar Sorteren op titel	Geciteerd door Geciteerd door	Jaar
Eliciting willingness to pay without bias: evidence from a field experiment K Blumenschein, GC Blomquist, M Johannesson, N Horn, P Freeman The Economic Journal 118 (525), 114-137, 2008	481	2008
Hypothetical versus real willingness to pay in the health care sector: results from a field experiment K Blumenschein, M Johannesson, K Yokoyama, P Freeman Value in Health 4 (2), 79-79, 2001	303	2001
Assessment of the relationship between measures of disease severity, quality of life, and willingness to pay in asthma AJ Zillich, K Blumenschein, M Johannesson, P Freeman Pharmacoeconomics 20, 257-265, 2002	91	2002
The changing landscape of naloxone availability in the United States, 2011–2017 PR Freeman, ER Hankosky, MR Lofwall, JC Talbert Drug and alcohol dependence 191, 361-364, 2018	90	2018
Association of naloxone coprescription laws with naloxone prescription dispensing in the United States M Sohn, JC Talbert, Z Huang, MR Lofwall, PR Freeman JAMA network open 2 (6), e196215-e196215, 2019	82	2019
Pharmacists’ role in opioid overdose: Kentucky pharmacists’ willingness to participate in naloxone dispensing PR Freeman, A Goodin, SZ Troske, A Strahl, A Fallin, TC Green Journal of the American Pharmacists Association 57 (2), S28-S33, 2017	81	2017
Buprenorphine dispensing in an epicenter of the US opioid epidemic: a case study of the rural risk environment in Appalachian Kentucky HLF Cooper, DH Cloud, PR Freeman, M Fadanelli, T Green, C Van Meter, ... International Journal of Drug Policy 85, 102701, 2020	80	2020
The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through … SL Walsh, N El-Bassel, RD Jackson, JH Samet, M Aggarwal, AP Aldridge, ... Drug and alcohol dependence 217, 108335, 2020	69	2020
The opioid-overdose reduction continuum of care approach (ORCCA): evidence-based practices in the HEALing communities study T Winhusen, A Walley, LC Fanucchi, T Hunt, M Lyons, M Lofwall, ... Drug and alcohol dependence 217, 108325, 2020	64	2020
Features of prescription drug monitoring programs associated with reduced rates of prescription opioid-related poisonings NJ Pauly, S Slavova, C Delcher, PR Freeman, J Talbert Drug and alcohol dependence 184, 26-32, 2018	64	2018
Implementation of personalized medicine services in community pharmacies: perceptions of independent community pharmacists KM Alexander, HS Divine, CR Hanna, Y Gokun, PR Freeman Journal of the American Pharmacists Association 54 (5), 510-517, 2014	64	2014
Trends and patterns of opioid analgesic prescribing: Regional and rural‐urban variations in Kentucky from 2012 to 2015 H Luu, S Slavova, PR Freeman, M Lofwall, S Browning, H Bush The Journal of Rural Health 35 (1), 97-107, 2019	56	2019
Utilization of prescription drug monitoring programs for prescribing and dispensing decisions: Results from a multi-site qualitative study PR Freeman, GM Curran, KL Drummond, BC Martin, BS Teeter, K Bradley, ... Research in Social and Administrative Pharmacy 15 (6), 754-760, 2019	54	2019
Community engagement to implement evidence-based practices in the HEALing communities study LS Martinez, BD Rapkin, A Young, B Freisthler, LS Glasgow, T Hunt, ... Drug and alcohol dependence 217, 108326, 2020	49	2020
When prescribing isn't enough-pharmacy-level barriers to buprenorphine access HLF Cooper, DH Cloud, AM Young, PR Freeman The New England journal of medicine 383 (8), 703-705, 2020	49	2020
Trends in gabapentin prescribing in a commercially insured US adult population, 2009-2016 NJ Pauly, C Delcher, S Slavova, E Lindahl, J Talbert, PR Freeman Journal of managed care & specialty pharmacy 26 (3), 246-252, 2020	48	2020
Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptor antagonist. LA Cassis, PE Rippetoe, EE Soltis, DJ Painter, R Fitz, MN Gillespie Journal of Pharmacology and Experimental Therapeutics 262 (3), 1168-1172, 1992	46	1992
Consumer/patient encounters with prescription drug monitoring programs: evidence from a Medicaid population A Goodin, K Blumenschein, PR Freeman, J Talbert Pain physician 15 (3 Suppl), ES169, 2012	41	2012
Polyamines and epidermal growth factor in monocrotaline-induced pulmonary hypertension. MN Gillespie, PE Rippetoe, CA Haven, RT Shiao, U Orlinska, BE Maley, ... American Journal of Respiratory and Critical Care Medicine 140 (5), 1463-1466, 1989	41	1989
Smooth muscle actin and myosin expression in cultured airway smooth muscle cells JZ Wong, J Woodcock-Mitchell, J Mitchell, P Rippetoe, S White, M Absher, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 274 (5 …, 1998	39	1998

Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.

Artikelen 1–20

Citaties per jaar

Dubbele citaties

Samengevoegde citaties

Medeauteurs toevoegenMedeauteurs

Volgen

Geciteerd door

Medeauteurs